|
|
Zimmer Biomet Holdings Inc (ZBH) |
|
|
|
| |
Zimmer Biomet Holdings Inc 's Long Term Debt to Equity
ZBH's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth
Due to long-term debt repayement of -1.19% Zimmer Biomet Holdings Inc improved Long Term Debt to Equity in third quarter 2023 to 0.41, below the company's average Long Term Debt to Equity.
Within Medical Equipment & Supplies industry in the third quarter 2023, 49 other companies have achieved lower Long Term Debt to Equity than Zimmer Biomet Holdings Inc in the III Quarter 2023. While Long Term Debt to Equity total ranking has improved so far in the third quarter 2023 to 1170, from total ranking in the second quarter 2023 at 1327 .
Explain Long Term Debt to Equity Ratio?
How much Long Term Debt ZBH´s has?
What is the structure of ZBH´s Equity?
|
Select the Comparisons :
|
|
Select the Ratio:
|
Long Term Debt to Equity ▼
|
Long Term Debt to Equity ▼
|
| ZBH Long Term Debt to Equity |
(Sep 30 2023)
III. Quarter |
(Jun 30 2023)
II. Quarter |
(Mar 31 2023)
I. Quarter |
(Dec 31 2022)
IV. Quarter |
(Sep 30 2022)
III. Quarter |
| Y / Y Equity Change |
2.18 % |
2.09 % |
1.13 % |
-5.05 % |
-3.64 % |
| Y / Y Long Term Debt Change |
1.43 % |
0.34 % |
-1.54 % |
-5.7 % |
-21.72 % |
| Long Term Debt to Equity MRQ |
0.41 |
0.42 |
0.43 |
0.43 |
0.41 |
| ZBH's Total
Ranking |
# 1170 |
# 1327 |
# 1431 |
# 478 |
# 1218 |
| Seq. Equity Change |
1.13 % |
1.82 % |
1.09 % |
-1.83 % |
1.04 % |
| Seq. Long Term Debt Change |
-1.19 % |
-0.3 % |
1.02 % |
1.92 % |
-2.26 % |
| Long Term Debt to Equity third quarter 2023 Company Ranking |
| Within: |
No. |
| Medical Equipment & Supplies Industry |
# 50 |
| Healthcare Sector |
# 158 |
| Overall Market |
# 1170 |
| Long Term Debt to Equity Statistics |
| High |
Average |
Low |
| 1.17 |
0.69 |
0.27 |
| (Sep 30 2015) |
|
(Dec 31 2013) |
Cumulative Zimmer Biomet Holdings Inc 's Long Term Debt to Equity
ZBH's Long Term Debt to Equity for the trailling 12 Months
ZBH Long Term Debt to Equity |
(Sep 30 2023)
III. Quarter |
(Jun 30 2023)
II. Quarter |
(Mar 31 2023)
I. Quarter |
(Dec 31 2022)
IV. Quarter |
(Sep 30 2022)
III. Quarter |
| Y / Y Equity TTM Growth |
2.18 % |
2.09 % |
1.13 % |
-5.05 % |
-3.64 % |
| Y / Y Long Term Debt TTM Growth |
1.43 % |
0.34 % |
-1.54 % |
-5.7 % |
-21.72 % |
| Long Term Debt to Equity TTM |
0.42 |
0.42 |
0.42 |
0.43 |
0.43 |
| Total
Ranking TTM |
# 83
| # 77
| # 9
| # 610
| # 83
|
| Seq. Equity TTM Growth |
1.13 % |
1.82 % |
1.09 % |
-1.83 % |
1.04 % |
| Seq. Long Term Debt TTM Growth |
-1.19 % |
-0.3 % |
1.02 % |
1.92 % |
-2.26 % |
On the trailing twelve months basis Due to long-term debt repayement of -1.19% Zimmer Biomet Holdings Inc has not changed Long Term Debt to Equity in the 12 months ending in III Quarter 2023 to 0.42, a new company low. Long Term Debt to Equity is the average cumulative value over the last four quarters.
Among companies in the Medical Equipment & Supplies industry 4, during the past 12 months, other companies have achieved lower Long Term Debt to Equity than Zimmer Biomet Holdings Inc . While Long Term Debt to Equity total ranking has deteriorated during the twelve months ending in the III Quarter 2023, compared to the prior period, from 77 to 83.
Explain Long Term Debt to Equity Ratio?
How much Long Term Debt ZBH´s has?
What is the structure of ZBH´s Equity?
| TTM Long Term Debt to Equity Company Ranking |
| Within: |
No. |
| Within the Medical Equipment & Supplies Industry |
# 5 |
| Healthcare Sector |
# 17 |
| Within the Market |
# 83 |
| trailing twelve months Long Term Debt to Equity Statistics |
| High |
Average |
Low |
| 0.9 |
0.61 |
0.42 | | (Dec 31 2017) |
|
(Sep 30 2023) |
| Companies with similar Long Term Debt to Equity in the quarter ending Sep 30 2023, within Medical Equipment & Supplies Industry | Long Term Debt to Equity | Sep 30 2023 MRQ Long Term Debt | Sep 30 2023 MRQ Equity | | Artivion Inc | 1.12 | $ 305.877 Millions | $ 271.975 Millions | | Acutus Medical Inc | 1.10 | $ 34.761 Millions | $ 31.706 Millions | | Dexcom Inc | 1.07 | $ 2,432.400 Millions | $ 2,267.900 Millions | | Sonendo Inc | 0.98 | $ 37.202 Millions | $ 37.780 Millions | | Zynex inc | 0.98 | $ 57.375 Millions | $ 58.582 Millions | | Neuronetics Inc | 0.97 | $ 36.851 Millions | $ 37.941 Millions | | Strata Skin Sciences Inc | 0.93 | $ 15.016 Millions | $ 16.193 Millions | | Integra Lifesciences Holdings Corp | 0.90 | $ 1,419.616 Millions | $ 1,579.221 Millions | | Medinotec Inc | 0.87 | $ 2.239 Millions | $ 2.567 Millions | | Haemonetics Corporation | 0.84 | $ 748.662 Millions | $ 893.660 Millions | | Msa Safety Inc | 0.82 | $ 715.814 Millions | $ 868.726 Millions | | Carlisle Companies Incorporated | 0.78 | $ 2,283.200 Millions | $ 2,923.800 Millions | | Icu Medical Inc | 0.76 | $ 1,589.244 Millions | $ 2,098.356 Millions | | Zimvie Inc | 0.73 | $ 515.533 Millions | $ 710.199 Millions | | Masimo Corp | 0.71 | $ 910.100 Millions | $ 1,275.600 Millions | | Cadre Holdings inc | 0.69 | $ 130.309 Millions | $ 189.997 Millions | | Nevro Corp | 0.66 | $ 187.803 Millions | $ 285.666 Millions | | National Vision Holdings Inc | 0.66 | $ 552.191 Millions | $ 840.352 Millions | | Bausch and Lomb Corp | 0.64 | $ 4,435.000 Millions | $ 6,883.000 Millions | | Integer Holdings Corporation | 0.64 | $ 941.383 Millions | $ 1,463.349 Millions | | Outset Medical Inc | 0.64 | $ 96.784 Millions | $ 152.063 Millions | | Infusystem Holdings Inc | 0.63 | $ 32.655 Millions | $ 51.469 Millions | | Glaukos Corp | 0.59 | $ 282.430 Millions | $ 477.659 Millions | | P3 Health Partners Inc | 0.58 | $ 108.252 Millions | $ 187.943 Millions | | Becton Dickinson And Company | 0.57 | $ 14,738.000 Millions | $ 25,796.000 Millions | | Steris Plc | 0.54 | $ 3,366.241 Millions | $ 6,189.168 Millions | | Dentsply Sirona Inc | 0.53 | $ 1,803.000 Millions | $ 3,371.000 Millions | | Silk Road Medical Inc | 0.49 | $ 75.364 Millions | $ 153.142 Millions | | Beyond Air Inc | 0.49 | $ 14.044 Millions | $ 28.831 Millions | | Axogen inc | 0.47 | $ 46.378 Millions | $ 97.810 Millions |
|
